{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T02:16:30Z","timestamp":1789697790018,"version":"4.0.1"},"reference-count":48,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2012,5,30]],"date-time":"2012-05-30T00:00:00Z","timestamp":1338336000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pediatric Blood &amp; Cancer"],"published-print":{"date-parts":[[2012,11]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Successful treatment of recurrent hepatoblastoma (HB) relies largely on surgical resection. When tumors are responsive, chemotherapy can be used to render patients resectable. Various chemotherapeutic regimens studied in small numbers of patients on phase I\/II trials have shown few responses. The best available data indicate that doxorubicin, if not given during intial treatment, and irinotecan are the most active agents in recurrent HB. Stem cell transplantation and radiation therapy have been reported in several patients with unclear successes. Advances in therapy for relapsed patients require concentrating enrollment in one or two phase I\/II trials utilizing agents with promising preclinical data. Pediatr Blood Cancer 2012; 59: 813\u2013817. \u00a9 2012 Wiley Periodicals, Inc.<\/jats:p>","DOI":"10.1002\/pbc.24218","type":"journal-article","created":{"date-parts":[[2012,5,30]],"date-time":"2012-05-30T14:12:25Z","timestamp":1338387145000},"page":"813-817","source":"Crossref","is-referenced-by-count":18,"title":["Relapsed hepatoblastoma"],"prefix":"10.1002","volume":"59","author":[{"given":"Angela D.","family":"Trobaugh\u2010Lotrario","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James H.","family":"Feusner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2012,5,30]]},"reference":[{"key":"e_1_2_10_2_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19930201)71:3<859::AID-CNCR2820710333>3.0.CO;2-T"},{"key":"e_1_2_10_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpedsurg.2007.08.030"},{"key":"e_1_2_10_4_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-964873"},{"key":"e_1_2_10_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/0022-3468(91)90678-M"},{"key":"e_1_2_10_6_2","doi-asserted-by":"publisher","DOI":"10.1002\/mpo.2950240113"},{"key":"e_1_2_10_7_2","doi-asserted-by":"publisher","DOI":"10.1097\/00043426-199703000-00016"},{"key":"e_1_2_10_8_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2006.09.7204"},{"key":"e_1_2_10_9_2","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.20330"},{"key":"e_1_2_10_10_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-04-1959"},{"key":"e_1_2_10_11_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19950615)75:12<2966::AID-CNCR2820751226>3.0.CO;2-W"},{"key":"e_1_2_10_12_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00253234"},{"key":"e_1_2_10_13_2","first-page":"131","article-title":"Phase II trial of ifosfamide in children with malignant solid tumors","volume":"71","author":"Pratt CB","year":"1987","journal-title":"Cancer Treat Rep"},{"key":"e_1_2_10_14_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2002.20.1.88"},{"key":"e_1_2_10_15_2","doi-asserted-by":"publisher","DOI":"10.1097\/00043426-200202000-00006"},{"key":"e_1_2_10_16_2","doi-asserted-by":"publisher","DOI":"10.1002\/mpo.10300"},{"key":"e_1_2_10_17_2","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.22460"},{"key":"e_1_2_10_18_2","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.22407"},{"key":"e_1_2_10_19_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2006.09.5125"},{"key":"e_1_2_10_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2004.01.042"},{"key":"e_1_2_10_21_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-911X(199903)32:3<209::AID-MPO8>3.0.CO;2-0"},{"key":"e_1_2_10_22_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00685519"},{"key":"e_1_2_10_23_2","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.22544"},{"key":"e_1_2_10_24_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1701283"},{"key":"e_1_2_10_25_2","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.20404"},{"key":"e_1_2_10_26_2","doi-asserted-by":"publisher","DOI":"10.1097\/00043426-200212000-00014"},{"key":"e_1_2_10_27_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1442-200X.2002.01549.x"},{"key":"e_1_2_10_28_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-3046.2008.00948.x"},{"key":"e_1_2_10_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/0360-3016(92)90007-5"},{"key":"e_1_2_10_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/0022-3468(77)90612-1"},{"key":"e_1_2_10_31_2","first-page":"383","article-title":"Chemotherapy, radiotherapy, and hepatic lobectomy for hepatoblastoma in an infant: Report of a survival","volume":"68","author":"Hermann RE","year":"1970","journal-title":"Surgery"},{"key":"e_1_2_10_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/0360-3016(95)00520-9"},{"key":"e_1_2_10_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/0277-5379(91)90229-7"},{"key":"e_1_2_10_34_2","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1542\/peds.86.6.937","article-title":"Interleukin\u20102 immunotherapy in children","volume":"86","author":"Chien CH","year":"1990","journal-title":"Pediatrics"},{"key":"e_1_2_10_35_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1997.15.11.3330"},{"key":"e_1_2_10_36_2","first-page":"3034","article-title":"A phase I trial and pharmacokinetic study of 9\u2010cis\u2010retinoic acid (alrt 1057) in pediatric patients with refractory cancer: A joint pediatric oncology branch, national cancer institute, and children's cancer group study","volume":"7","author":"Adamson PC","year":"2001","journal-title":"Clin Cancer Res"},{"key":"e_1_2_10_37_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.03.9271"},{"key":"e_1_2_10_38_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.11.429"},{"key":"e_1_2_10_39_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.11.9230"},{"key":"e_1_2_10_40_2","doi-asserted-by":"publisher","DOI":"10.1097\/00043426-199807000-00006"},{"key":"e_1_2_10_41_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.11.6103"},{"key":"e_1_2_10_42_2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.21779"},{"key":"e_1_2_10_43_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1997.15.4.1538"},{"key":"e_1_2_10_44_2","first-page":"733","article-title":"Phase I trial of docetaxel with filgrastim support in pediatric patients with refractory solid tumors: A collaborative pediatric oncology branch, national cancer institute and children's cancer group trial","volume":"5","author":"Seibel NL","year":"1999","journal-title":"Clin Cancer Res"},{"key":"e_1_2_10_45_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2003.08.175"},{"key":"e_1_2_10_46_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19940215)73:4<1297::AID-CNCR2820730427>3.0.CO;2-#"},{"key":"e_1_2_10_47_2","doi-asserted-by":"publisher","DOI":"10.1097\/00043426-200307000-00008"},{"key":"e_1_2_10_48_2","doi-asserted-by":"publisher","DOI":"10.1054\/bjoc.2000.1637"},{"key":"e_1_2_10_49_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002371-199208000-00009"}],"container-title":["Pediatric Blood &amp; Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fpbc.24218","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fpbc.24218","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/pbc.24218","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,9]],"date-time":"2023-10-09T10:30:34Z","timestamp":1696847434000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/pbc.24218"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5,30]]},"references-count":48,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012,11]]}},"alternative-id":["10.1002\/pbc.24218"],"URL":"https:\/\/doi.org\/10.1002\/pbc.24218","archive":["Portico"],"relation":{},"ISSN":["1545-5009","1545-5017"],"issn-type":[{"value":"1545-5009","type":"print"},{"value":"1545-5017","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,5,30]]}}}